ALLK
Price
$0.33
Change
-$0.00 (-0.00%)
Updated
Apr 24 closing price
Capitalization
29.52M
12 days until earnings call
ELAB
Price
$2.22
Change
-$0.69 (-23.71%)
Updated
Apr 24 closing price
Capitalization
1.57M
Ad is loading...

ALLK vs ELAB

Header iconALLK vs ELAB Comparison
Open Charts ALLK vs ELABBanner chart's image
Allakos
Price$0.33
Change-$0.00 (-0.00%)
Volume$126.02K
Capitalization29.52M
PMGC Holdings
Price$2.22
Change-$0.69 (-23.71%)
Volume$5.4M
Capitalization1.57M
ALLK vs ELAB Comparison Chart
Loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLK vs. ELAB commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a Buy and ELAB is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ALLK: $0.33 vs. ELAB: $2.22)
Brand notoriety: ALLK and ELAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 9% vs. ELAB: 851%
Market capitalization -- ALLK: $29.52M vs. ELAB: $1.57M
ALLK [@Biotechnology] is valued at $29.52M. ELAB’s [@Biotechnology] market capitalization is $1.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileELAB’s FA Score has 1 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • ELAB’s FA Score: 1 green, 4 red.
According to our system of comparison, ALLK is a better buy in the long-term than ELAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 4 TA indicator(s) are bullish while ELAB’s TA Score has 5 bullish TA indicator(s).

  • ALLK’s TA Score: 4 bullish, 5 bearish.
  • ELAB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, ELAB is a better buy in the short-term than ALLK.

Price Growth

ALLK (@Biotechnology) experienced а +0.18% price change this week, while ELAB (@Biotechnology) price change was -14.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

ALLK is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALLK($29.5M) has a higher market cap than ELAB($1.57M). ALLK YTD gains are higher at: -73.008 vs. ELAB (-86.151). ELAB has higher annual earnings (EBITDA): -4.75M vs. ALLK (-111.04M). ALLK has more cash in the bank: 80.8M vs. ELAB (6.43M). ELAB has less debt than ALLK: ELAB (103K) vs ALLK (4.16M). ELAB has higher revenues than ALLK: ELAB (2.45M) vs ALLK (0).
ALLKELABALLK / ELAB
Capitalization29.5M1.57M1,879%
EBITDA-111.04M-4.75M2,339%
Gain YTD-73.008-86.15185%
P/E RatioN/AN/A-
Revenue02.45M-
Total Cash80.8M6.43M1,257%
Total Debt4.16M103K4,037%
FUNDAMENTALS RATINGS
ALLK: Fundamental Ratings
ALLK
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLKELAB
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
85%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 22 days ago
86%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PAGS9.610.37
+4.00%
PagSeguro Digital Ltd
CMI293.9610.29
+3.63%
Cummins
ABEO5.390.17
+3.26%
Abeona Therapeutics
BTCS1.830.03
+1.67%
BTCS
FSM6.130.04
+0.66%
Fortuna Mining Corp

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with VERU. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then VERU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
+0.28%
VERU - ALLK
50%
Loosely correlated
N/A
AXON - ALLK
38%
Loosely correlated
+2.39%
IMCR - ALLK
33%
Loosely correlated
+1.88%
AMRN - ALLK
32%
Poorly correlated
+7.92%
GANX - ALLK
31%
Poorly correlated
+1.62%
More

ELAB and

Correlation & Price change

A.I.dvisor tells us that ELAB and EPIX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELAB and EPIX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-23.71%
EPIX - ELAB
30%
Poorly correlated
+2.27%
LXRX - ELAB
25%
Poorly correlated
+4.70%
EDSA - ELAB
22%
Poorly correlated
+0.86%
REGN - ELAB
20%
Poorly correlated
+2.03%
ALLK - ELAB
20%
Poorly correlated
+0.28%
More